bismuth has been researched along with Leukemia-Lymphoma, Adult T-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brechbiel, MW; Gansow, OA; Garmestani, K; Hartmann, F; Horak, EM; Kosteiny, SA; Kozak, RW; Nelson, DL; Tso, J; Wu, C | 1 |
| Waldmann, TA | 2 |
| Axworthy, DB; Brechbiel, MW; Carrasquillo, JA; Garmestani, K; Goldman, CK; Mallett, RW; Theodore, LJ; Waldmann, TA; Yao, Z; Zhang, M; Zhang, Z | 1 |
2 review(s) available for bismuth and Leukemia-Lymphoma, Adult T-Cell
| Article | Year |
|---|---|
Genetically engineered monoclonal antibodies armed with radionuclides.
Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Bismuth; CD4 Antigens; CD4-Positive T-Lymphocytes; Gene Expression Regulation, Neoplastic; Humans; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Mice; Neoplasm Proteins; Neoplasms; Protein Engineering; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Yttrium Radioisotopes | 1993 |
Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma.
Topics: ADP Ribose Transferases; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Antibody-Dependent Cell Cytotoxicity; Bacterial Toxins; Bismuth; Exotoxins; Gene Expression Regulation, Neoplastic; HTLV-I Infections; Humans; Immunologic Deficiency Syndromes; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Mice; Molecular Sequence Data; Neoplasm Proteins; Protein Engineering; Pseudomonas aeruginosa Exotoxin A; Radioisotopes; Receptors, Interleukin-2; Virulence Factors; Yttrium Radioisotopes | 1994 |
2 other study(ies) available for bismuth and Leukemia-Lymphoma, Adult T-Cell
| Article | Year |
|---|---|
Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Dose-Response Relationship, Immunologic; Drug Screening Assays, Antitumor; Humans; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Nude; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Receptors, Interleukin-2; Tissue Distribution | 1994 |
Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha-emitting radionuclide, bismuth 213.
Topics: Alpha Particles; Animals; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biotin; Bismuth; Heterocyclic Compounds, 1-Ring; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Inbred NOD; Neoplasms, Experimental; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Receptors, Interleukin-2; Streptavidin; Survival Rate; Treatment Outcome | 2002 |